NDC 17856-0517-7 - Morphine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0517
- Requested NDC
- 17856-0517-7
- Package NDCs from labels
- 17856-0517-5, 17856-0517-1, 17856-0517-7, 17856-0517-3, 17856-0517-6, 17856-0517-2, 17856-0517-8, 17856-0517-4
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2023-06-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Morphine Sulfate - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2023-06-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0517-1 | Morphine Sulfate | 60 in 1 BOX, UNIT-DOSE | SOLUTION | 60 | 4 | |
| 17856-0517-2 | Morphine Sulfate | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | 4 | |
| 17856-0517-3 | Morphine Sulfate | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | 4 | |
| 17856-0517-4 | Morphine Sulfate | 120 in 1 BOX, UNIT-DOSE | SOLUTION | 120 | 4 | |
| 17856-0517-5 | Morphine Sulfate | 0.25 mL in 1 SYRINGE | SOLUTION | 0.25 | 4 | |
| 17856-0517-6 | Morphine Sulfate | 1.0 mL in 1 SYRINGE | SOLUTION | 1.0 | 4 | |
| 17856-0517-7 | Morphine Sulfate | 0.25 mL in 1 SYRINGE | SOLUTION | 0.25 | 4 | |
| 17856-0517-8 | Morphine Sulfate | 1 mL in 1 SYRINGE | SOLUTION | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0517 | MORPHINE SULFATE SOLUTION [ATLANTIC BIOLOGICALS CORP.] | 4 | Legacy NDC, 8 package rows | 20230616_839923b4-4b4c-4745-baa5-4d27d4dbb5e7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lemon Glycerin | GLYCERIN | Dynarex Corporation | 99fc00ea-9d55-0380-e053-2995a90a2c0b | 2026-03-24 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | 059QF0KO0R |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| Morphine sulfate | MORPHINE SULFATE | Sun Pharmaceutical Industries, Inc. | 736c9b80-682c-4cda-bf18-61b18de0bd39 | 2026-03-15 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Optimel Manuka Dry Eye Drops | GLYCERIN | Melcare Biomedical Pty Ltd | 88c5e2f0-9f7e-62d1-e053-2995a90a9014 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Optimel Manuka Forte Eye Gel | GLYCERIN | Melcare Biomedical Pty Ltd | 8e0ed6e8-51fc-7c5b-e053-2a95a90a35a9 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 31778652-e60e-4098-8e90-3e4f56b5800c | 2026-03-06 | Warnings | PDC6A3C0OX |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Morphine sulfate | MORPHINE SULFATE | Actavis Pharma, Inc. | 2da87bfa-11fd-43e3-8fef-d16ebeb15680 | 2026-03-01 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Tricitrates | TRICITRATES | Chartwell Governmental & Specialty RX, LLC. | c4ff0407-3930-4c48-afd4-d2cb3e1b18f4 | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC. | fd57a176-7faf-4053-b348-6ba5f192f05a | 2026-02-25 | Warnings, Adverse reactions | 2968PHW8QP |
| MITIGO | MORPHINE SULFATE | Piramal Critical Care, Inc. | 728f3d83-9a63-0c1f-e053-2a91aa0ac7db | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| Morphine Sulfate | MORPHINE SULFATE | Cranbury Pharmaceuticals, LLC | d8598654-94ad-4cfb-81d2-9b68e013a428 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | 892625 892589 X3P646A2J0 |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 07993f6c-146b-4728-a2da-6e93089f78ff | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | X3P646A2J0 |
| WowDay Hemorrhoid and Fissure Cream | HEMORRHOID AND FISSURE CREAM | WowDay LLC | 47ba86ad-240a-e733-e063-6394a90a24e3 | 2026-02-12 | Warnings | PDC6A3C0OX |
| Viva Hydration Boost | GLYCERIN | Nomax Inc | 174193b2-65eb-b5fd-e063-6394a90a9cd0 | 2026-02-10 | Warnings | PDC6A3C0OX |
| Morphine Sulfate | MORPHINE SULFATE | American Health Packaging | 66a3f607-7f48-490f-84dd-b74dd1ee39e5 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 892589 X3P646A2J0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.